CAREGIVER BURDEN IN PARKINSON 'S DISEASE WITH HYPERTENTION

Ngọc Dũng Hoàng1,2,, Viết Lực Trần1,2
1 Hanoi medical university
2 National Geriatric Hospital

Main Article Content

Abstract

Objective:  Assess the caregiver burden (CB) in Parkinson 's disease with hypertention. Method: A total of 50 patients who were diagnosed as having IPD with hypertention by neurologist according to United Kingdom Brain Bank Criteria, 2020 International Society of hypertention Global Hypertention Practice Guielines and their caregivers were randomly selected for participation the study. Staging of PD was performed by determined using the Unified Parrkinson 's Disease rating scale (UPDRS). CB was evaluated using the Zarit Caregiver Burden Inventory (ZBI). The Depression Anxiety and Stress Scale 21 (DASS-21) was used to assess anxiety and depressive symtoms in patients with IPD and their caregivers. Parrkinson 's Disease Questionnaire – 39 (PDQ-39) was used to evaluate quality of life of the patients. The Mini – Mental State Examination (MMSE) was administered to patients to evaluate gross cognitive status. Results: 50 main caregivers of Parkinson 's patients with hypertention were included in our study. The mean ZBI score of study group was 23,52±13,841 There was a significant difference between the mean ZBI score of the two group of caregivers for Parkinson 's patients with stage 1 and stage 2 hypertention (p<0,05). In group of caregivers for Parkinson 's patients with stage 2 hypertention, the average PDQ-carer score was 37,72±17,603, compared with 24,96±15,199 in the group of caregivers for Parkinson 's patients with stage 1 hypertention. There was a difference between the two group with p<0,05. Conclusion: The caregiver burden for Parkinson 's patient was increased in Parkinson 's patients with hypertention.

Article Details

References

1. Tarakad A, Jankovic J. Diagnosis and Management of Parkinson’s Disease. Semin Neurol. 2017;37(02):118-126. doi:10.1055/s-0037-1601888
2. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026
3. Wang X, Zeng F, Jin WS, et al. Comorbidity burden of patients with Parkinson’s disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China. Sci Rep. 2017;7:1671. doi:10.1038/s41598-017-01795-0
4. The global epidemiology of hypertension - PMC. Accessed October 2, 2022. https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC7998524/
5. Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(6):629-634. doi:10.1016/j.parkreldis.2015.03.024
6. Ozdilek B, Gunal DI. Motor and non-motor symptoms in Turkish patients with Parkinson’s disease affecting family caregiver burden and quality of life. J Neuropsychiatry Clin Neurosci. 2012;24(4):478-483. doi:10.1176/appi.neuropsych.11100315
7. Macchi ZA, Koljack CE, Miyasaki JM, et al. Patient and caregiver characteristics associated with caregiver burden in Parkinson’s disease: a palliative care approach. Ann Palliat Med. 2020;9(Suppl 1):S24-S33. doi:10.21037/apm.2019.10.01
8. Genç F, Yuksel B, Tokuc FEU. Caregiver Burden and Quality of Life in Early and Late Stages of Idiopathic Parkinson’s Disease. Psychiatry Investig. 2019;16(4):285-291. doi: 10.30773/pi.2019.02.20